Abcam & Cancer Research UK join forces to accelerate cancer research

By Akshay Kedari  Date: 2020-07-09

Abcam & Cancer Research UK join forces to accelerate cancer research

Cancer Research UK, one of the world's biggest independent funder of cancer research, has recently joined forces with Abcam plc, a leading developer of life science tools and reagents, to commercialize and develop novel custom antibodies to strengthen cancer research.

According to the terms of this partnership, Abcam would create custom protein-based reagents to targets that are recognized by researchers at Cancer Research UK. These antibodies would support the ongoing research and progress the understanding of cancer biology. Moreover, it would potentially be the basis for novel therapies as well as help generate new diagnostic tools.

Upon request, Abcam would deliver unique antibodies created during the terms of the agreement to researchers funded by Cancer Research UK for a pre-determined span of exclusivity in correspondence to that antibody. 

Meanwhile, Abcam’s co-location in key technology spots throughout the world and global supply capability would allow these innovative reagents to be easily available across wider diagnostic and research development community.

Speaking on the move, Tony Hickson, CBO, Cancer Research UK, said that the company is thrilled to collaborate with Abcam to develop tools that scientists require to help advance their understanding of cancer and to extend its access to biological reagents.

Additionally, Abcam’s “end-to-end” expertise and antibody development capabilities would support works of numerous researchers with antibody reagents that could be utilized from the initial stages of R&D right to the clinical trials.

As for Dr. John Baker, SVP of Product Portfolio Innovation, Abcam, the company is delighted to partner with Cancer Research UK to strengthen research by scientist and offer them easy access to validated and specific reagents, thereby helping them attain future breakthrough quickly.

Prior to this news, Abcam had made headlines when it announced that it has purchased assets of oncology product portfolio and gene editing platform from Applied StemCell, Inc. (ASC) for life science diagnostic and research markets. 
 

Source credit: https://www.abcam.com/index.html?pageconfig=news&rid=17091

About Author

Akshay Kedari     aeresearch.net

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Tesla gets German nod to develop test cars at unfinished Berlin factory

Tesla gets German nod to develop test cars at unfinished Berlin factory

By Akshay Kedari

Tesla Inc. has reportedly received authorization to produce test cars at its unfinished German gigafactory. This approval comes as the EV maker continues to wait for the project's final permission, although Tesla will not be permitted to sell the...

Power Gummies secures USD 6 million in 9Unicorns-led Series A funding

Power Gummies secures USD 6 million in 9Unicorns-led Series A funding

By Akshay Kedari

Nutraceutical startup Power Gummies has reportedly raised USD 6 million during a Series A funding which was led by 9Unicorns. The round also saw participation from other investors such as NB Ventures, Sharpp Ventures (Marico Family Office), Wipr...

Marriot establishes a research & development lab to promote innovation

Marriot establishes a research & development lab to promote innovation

By Akshay Kedari

Hospitality behemoth Marriott International Inc. has reportedly established a research and development lab called the “Design Lab” to strengthen and optimize the rollout of its current product offerings. This lab will encompass all areas...

Sony to steer into the electric vehicle space with a new mobility unit

Sony to steer into the electric vehicle space with a new mobility unit

By Akshay Kedari

Sony will establish a subsidiary, ‘Sony Mobility Inc.’ that will primarily focus on its EV business. The company unveiled a new electric SUV prototype, called the Vision-S 02 at CES 2022. Sony Group Corporation, a Japanese electroni...

Apple becomes world's first company to reach USD 3 trillion valuation

Apple becomes world's first company to reach USD 3 trillion valuation

By Akshay Kedari

Apple Inc. recently became the first company to have a stock market value of USD 3 trillion, boosted by investor confidence that the iPhone manufacturer will continue to release best-selling products while foraying into new markets such as self-drivi...